ELOB and neoplasm: The disruption of genes such as suppressors of cytokine signaling 1 (SOCS1), Tet methyl cytosine dioxygenase 2 (TET2), and transcription elongation factor B polypeptide 2 (TCEB2) have been shown to enhance T cell expansion and tumor-specific cytotoxicity (54).